Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Adverse reactions to thalidomide in patients infected with human immunodeficiency virus.

Haslett P, Tramontana J, Burroughs M, Hempstead M, Kaplan G.

Clin Infect Dis. 1997 Jun;24(6):1223-7.

PMID:
9195087
[PubMed - indexed for MEDLINE]
Free Article
2.

Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267.

Wohl DA, Aweeka FT, Schmitz J, Pomerantz R, Cherng DW, Spritzler J, Fox L, Simpson D, Bell D, Holohan MK, Thomas S, Robinson W, Kaplan G, Teppler H; National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group 267.

J Infect Dis. 2002 May 1;185(9):1359-63. Epub 2002 Apr 16.

PMID:
12001058
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia.

Phanuphak P, Grayson ML, Sirivichayakul S, Suwanagool S, Ruxrungtham K, Hanvanich M, Ratanasuwan W, Ubolyam S, Hughes MD, Wanke CA, Hammer SM.

Aust N Z J Med. 2000 Feb;30(1):11-20.

PMID:
10800872
[PubMed - indexed for MEDLINE]
5.

Long-term follow-up of asymptomatic HIV-infected patients who discontinued antiretroviral therapy.

Fernández Guerrero ML, Rivas P, Molina M, Garcia R, De Górgolas M.

Clin Infect Dis. 2005 Aug 1;41(3):390-4. Epub 2005 Jun 22.

PMID:
16007538
[PubMed - indexed for MEDLINE]
Free Article
6.

The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection.

Klausner JD, Makonkawkeyoon S, Akarasewi P, Nakata K, Kasinrerk W, Corral L, Dewar RL, Lane HC, Freedman VH, Kaplan G.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Mar 1;11(3):247-57.

PMID:
8603261
[PubMed - indexed for MEDLINE]
7.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
[PubMed - indexed for MEDLINE]
8.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
[PubMed - indexed for MEDLINE]
9.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.

PMID:
12027060
[PubMed - indexed for MEDLINE]
Free Article
10.
11.

T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).

Casseb J, Posada-Vergara MP, Montanheiro P, Fukumori LM, Olah I, Smid J, Duarte AJ, Penalva de Oliveira AC.

Rev Inst Med Trop Sao Paulo. 2007 Jul-Aug;49(4):231-3.

PMID:
17823752
[PubMed - indexed for MEDLINE]
Free Article
12.

Crossover of human immunodeficiency virus-infected patients from aerosolized pentamidine to trimethoprim-sulfamethoxazole: lack of hematologic toxicity and relationship of side effects to CD4+ lymphocyte count.

Kennedy CA, Pimentel JA, Lewis DE, Anderson MD, Weiss PJ, Oldfield EC 3rd.

J Infect Dis. 1993 Aug;168(2):314-7.

PMID:
8101551
[PubMed - indexed for MEDLINE]
13.

A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.

Vella S, Lazzarin A, Carosi G, Sinicco A, Armignacco O, Angarano G, Andreoni M, Tambussi G, Chiodera A, Floridia M, Scaccabarozzi S, Facey K, Duncan I, Boudes P, Bragman K.

Antivir Ther. 1996 Aug;1(3):129-40.

PMID:
11322246
[PubMed - indexed for MEDLINE]
14.

Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.

García F, de Lazzari E, Plana M, Castro P, Mestre G, Nomdedeu M, Fumero E, Martínez E, Mallolas J, Blanco JL, Miró JM, Pumarola T, Gallart T, Gatell JM.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):702-13.

PMID:
15167289
[PubMed - indexed for MEDLINE]
15.

A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.

García F, Romeu J, Grau I, Sambeat MA, Dalmau D, Knobel H, Gomez-Sirvent JL, Arrizabalaga J, Cruceta A, Clotet BG, Podzamczer D, Pumarola T, Gallart T, O'Brien WA, Miró JM, Gatell JM.

AIDS. 1999 Dec 3;13(17):2377-88.

PMID:
10597779
[PubMed - indexed for MEDLINE]
16.

The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.

Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W.

Pediatrics. 2005 Apr;115(4):e488-94. Epub 2005 Mar 16.

PMID:
15772172
[PubMed - indexed for MEDLINE]
17.

Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.

Mocroft A, Staszewski S, Weber R, Gatell J, Rockstroh J, Gasiorowski J, Panos G, Monforte Ad, Rakhmanova A, Phillips AN, Lundgren JD; EuroSIDA study group.

Antivir Ther. 2007;12(3):325-33. Erratum in: Antivir Ther. 2007;12(4):577.

PMID:
17591022
[PubMed - indexed for MEDLINE]
18.

Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1.

Sperber K, Chiang G, Chen H, Ross W, Chusid E, Gonchar M, Chow R, Liriano O.

Clin Ther. 1997 Sep-Oct;19(5):913-23.

PMID:
9385480
[PubMed - indexed for MEDLINE]
19.

Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients.

Meynard JL, Barbut F, Guiguet M, Batisse D, Lalande V, Lesage D, Guiard-Schmid JB, Petit JC, Frottier J, Meyohas MC.

J Infect. 1999 May;38(3):176-81.

PMID:
10424798
[PubMed - indexed for MEDLINE]
20.

The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus.

Haslett P, Hempstead M, Seidman C, Diakun J, Vasquez D, Freedman VH, Kaplan G.

AIDS Res Hum Retroviruses. 1997 Aug 10;13(12):1047-54.

PMID:
9264292
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk